N‐Terminal Modification of Gly‐His‐Tagged Proteins with Azidogluconolactone

Site‐specific protein modifications are vital for biopharmaceutical drug development. Gluconoylation is a non‐enzymatic, post‐translational modification of N‐terminal HisTags. We report high‐yield, site‐selective in vitro α‐aminoacylation of peptides, glycoproteins, antibodies, and virus‐like partic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chembiochem : a European journal of chemical biology Ročník 22; číslo 22; s. 3199 - 3207
Hlavní autoři: Brune, Karl D., Liekniņa, Ilva, Sutov, Grigorij, Morris, Alexander R., Jovicevic, Dejana, Kalniņš, Gints, Kazāks, Andris, Kluga, Rihards, Kastaljana, Sabine, Zajakina, Anna, Jansons, Juris, Skrastiņa, Dace, Spunde, Karīna, Cohen, Alexander A., Bjorkman, Pamela J., Morris, Howard R., Suna, Edgars, Tārs, Kaspars
Médium: Journal Article
Jazyk:angličtina
Vydáno: Weinheim Wiley Subscription Services, Inc 16.11.2021
Témata:
Aminoacylation
Antibodies
Antigens
Biopharmaceuticals
click chemistry
COVID-19
COVID-19 vaccines
Drug development
Esters
Glycoproteins
Glycosylation
immunology
nanoparticles
Peptides
protein modifications
Proteins
R&D
Research & development
Seroconversion
Severe acute respiratory syndrome coronavirus 2
site-specific conjugation
Viruses
Yeast
ISSN:1439-4227, 1439-7633, 1439-7633
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Site‐specific protein modifications are vital for biopharmaceutical drug development. Gluconoylation is a non‐enzymatic, post‐translational modification of N‐terminal HisTags. We report high‐yield, site‐selective in vitro α‐aminoacylation of peptides, glycoproteins, antibodies, and virus‐like particles (VLPs) with azidogluconolactone at pH 7.5 in 1 h. Conjugates slowly hydrolyse, but diol‐masking with borate esters inhibits reversibility. In an example, we multimerise azidogluconoylated SARS‐CoV‐2 receptor‐binding domain (RBD) onto VLPs via click‐chemistry, to give a COVID‐19 vaccine. Compared to yeast antigen, HEK‐derived RBD was immunologically superior, likely due to observed differences in glycosylation. We show the benefits of ordered over randomly oriented multimeric antigen display, by demonstrating single‐shot seroconversion and best virus‐neutralizing antibodies. Azidogluconoylation is simple, fast and robust chemistry, and should accelerate research and development. Site‐selective α‐amino acylation of proteins with N‐terminal Gly‐HisTags using 6‐azido‐6‐deoxy‐glucono‐1,5‐lactone (6AGDL) is reported. To demonstrate the usefulness of this reaction, we multimerise the SARS‐CoV‐2 receptor‐binding domain (RBD) protein antigen onto virus‐like particles (VLPs) via strain‐promoted alkyne‐azide cycloaddition (SPAAC). The resulting COVID‐19 vaccine candidate induces single‐shot seroconversion, and virus‐neutralizing antibodies in mice.
Bibliografie:These authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1439-4227
1439-7633
1439-7633
DOI:10.1002/cbic.202100381